Clinical trials in malignant pleural mesothelioma in Australasia

Australasia has a strong record in clinical trials in malignant pleural mesothelioma (MPM), driven by the relatively high incidence of this disease in the region. Two current and three proposed trials in mesothelioma in this region are discussed, covering the diverse clinical scenarios of diagnosis and staging, health-related quality of life, maintenance therapy, prediction of response and combined modality treatment.